The alteration of placental-derived soluble MHC class I chain-related protein A and B during pregnancy

Acta Obstet Gynecol Scand. 2011 Jul;90(7):802-7. doi: 10.1111/j.1600-0412.2011.01131.x. Epub 2011 May 20.

Abstract

Objective: According to a novel mechanism for fetal evasion from maternal immune attack via the engagement and down-regulation of the maternal natural killer cell receptor NKG2D by soluble MHC class I chain-related proteins (sMIC) A and B derived from placenta, we aimed to measure whether the sMICA/B level altered during pregnancy.

Design and setting: Healthy women undergoing routine antepartum examination at Kee-Lung Chang Gung Memorial Hospital from December 2006 to December 2007 were prospectively registered for this study.

Samples: We collected 337 serum specimens and 10 amniotic fluid samples from 300 normal pregnant women for sMICA/B analysis.

Methods: Capture ELISA procedures were used to determine sMICA/B concentration in serum and amniotic fluid specimens.

Main outcome measures: We hypothesized that the sMICA/B level would increase in proportion to the gestational age to protect the fetus from maternal immune rejection in the normal pregnancy. Results. The serum sMICA/B level rose gradually with the progression of gestation and decreased after the second trimester, with the lowest level appearing before delivery. In addition, we found that levels of soluble MICA/B were extremely low in amniotic fluid.

Conclusions: We suggest that, as delivery approaches, the reduced production of soluble MICA/B by the aged placenta may be playing a role in parturition. Furthermore, we suggest that the effect of soluble MICA/B on natural killer cells of pregnant women is limited to the maternal placental surface, but not transferred through the placenta into the amniotic cavity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amniotic Fluid / immunology
  • Amniotic Fluid / metabolism*
  • Cohort Studies
  • Down-Regulation
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fetal Development / physiology
  • Gestational Age
  • Histocompatibility Antigens Class I / blood*
  • Histocompatibility Antigens Class I / immunology
  • Humans
  • Placenta / immunology
  • Placenta / physiology*
  • Pregnancy / immunology*
  • Pregnancy / metabolism*
  • Prenatal Care / methods
  • Prospective Studies
  • Reference Values
  • Solubility
  • Taiwan

Substances

  • Histocompatibility Antigens Class I
  • MHC class I-related chain A
  • MICB antigen